Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Bionor Pharma ASA Appoints Dr. Anker Lundemose New President and Chief Executive Officer


Tuesday, 29 Jan 2013 02:30am EST 

Bionor Pharma ASA announced that Dr. Anker Lundemose has been appointed new President and Chief Executive Officer (CEO) of Bionor Pharma ASA from March 1, 2013. Dr. Lundemose replaces Mr. Steen Kroyer, who has held the position of Interim CEO of the Company since September 2011, and who will take the position of Deputy Chairman of the Board of Directors in accordance with the nomination and election at the Company's Annual General Meeting of May 11, 2012. 

Company Quote

2.29
0.02 +0.88%
10:25am EDT